Townsquare Capital LLC Makes New Investment in LifeStance Health Group, Inc. (NASDAQ:LFST)

Townsquare Capital LLC bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 10,369 shares of the company’s stock, valued at approximately $73,000.

A number of other large investors also recently bought and sold shares of LFST. Price T Rowe Associates Inc. MD lifted its holdings in shares of LifeStance Health Group by 12.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company’s stock worth $262,000 after purchasing an additional 4,681 shares during the last quarter. California State Teachers Retirement System lifted its holdings in shares of LifeStance Health Group by 13.0% in the 1st quarter. California State Teachers Retirement System now owns 95,758 shares of the company’s stock worth $591,000 after purchasing an additional 11,022 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of LifeStance Health Group by 3.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 451,102 shares of the company’s stock worth $2,215,000 after purchasing an additional 15,309 shares during the last quarter. CIBC Asset Management Inc bought a new stake in shares of LifeStance Health Group in the 2nd quarter worth approximately $53,000. Finally, Rhumbline Advisers lifted its holdings in shares of LifeStance Health Group by 17.6% in the 2nd quarter. Rhumbline Advisers now owns 182,131 shares of the company’s stock worth $894,000 after purchasing an additional 27,280 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Up 1.7 %

LFST opened at $7.34 on Monday. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $9.20. The stock has a market cap of $2.81 billion, a P/E ratio of -28.23 and a beta of 1.28. The stock’s 50 day moving average price is $7.13 and its 200 day moving average price is $6.28. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company had revenue of $312.70 million for the quarter, compared to analysts’ expectations of $302.25 million. During the same period last year, the firm earned ($0.17) EPS. The firm’s revenue for the quarter was up 18.9% on a year-over-year basis. As a group, research analysts predict that LifeStance Health Group, Inc. will post -0.2 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on LFST shares. UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. Barclays raised their target price on LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $8.50.

Insider Activity

In other news, Director Robert Bessler sold 75,000 shares of LifeStance Health Group stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the transaction, the director now directly owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. This trade represents a 5.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 6.60% of the stock is owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.